Liberum Capital Reconfirms Town Centre Securities PLC (LON:TOWN) As “Buy”; Has Price Objective Of GBX 340.00; Argenx SE – American Depositary Shares (ARGX) Shorts Up By 67.6%

Argenx SE – American Depositary Shares (NASDAQ:ARGX) had an increase of 67.6% in short interest. ARGX’s SI was 126,200 shares in March as released by FINRA. Its up 67.6% from 75,300 shares previously. With 267,500 avg volume, 1 days are for Argenx SE – American Depositary Shares (NASDAQ:ARGX)’s short sellers to cover ARGX’s short positions. The SI to Argenx SE – American Depositary Shares’s float is 0.57%. The stock decreased 3.23% or $2.56 during the last trading session, reaching $76.63. About 127,956 shares traded. argenx SE (NASDAQ:ARGX) has 0.00% since March 1, 2017 and is . It has underperformed by 16.70% the S&P500.

In a research note revealed to clients on Thursday morning, Town Centre Securities PLC (LON:TOWN) stock had its “Buy” Rating reiterated by equity research analysts at Liberum Capital. They currently have a GBX 340.00 target price per share on firm. Liberum Capital’s target suggests a potential upside of 19.30% from the company’s current stock price.

argenx SE, a clinical-stage biopharmaceutical company, focuses on developing antibody therapies for the treatment of autoimmune diseases and cancer. The company has market cap of $2.46 billion. The companyÂ’s lead clinical stage product candidates include ARGX-113, a product in Phase 2 clinical trials for the treatment of autoimmune diseases, including myasthenia gravis and immune thrombocytopenia; and ARGX-110, which is in Phase 1/2 clinical trials for the treatment of hematological cancers, such as T-cell lymphoma, acute myeloid leukemia, and myelodysplastic syndrome. It currently has negative earnings. It is also developing ARGX-111 to treat solid tumors with MET amplification; ARGX-109 for the treatment of rheumatoid arthritis; ARGX-112 to treat skin inflammation; ARGX-115, a cancer immunotherapy-focused product candidate; and ARGX-116 for the treatment of dyslipidemia.

The stock increased 0.75% or GBX 2.1 during the last trading session, reaching GBX 282.1. About 9 shares traded. Town Centre Securities PLC (LON:TOWN) has 0.00% since March 1, 2017 and is . It has underperformed by 16.70% the S&P500.

The post Liberum Capital Reconfirms Town Centre Securities PLC (LON:TOWN) As “Buy”; Has Price Objective Of GBX 340.00; Argenx SE – American Depositary Shares (ARGX) Shorts Up By 67.6% appeared first on Stock Market News | HillCountryTimes | Get it Today.

from
https://www.hillcountrytimes.com/2018/03/01/liberum-capital-reconfirms-town-centre-securities-plc-lontown-as-buy-has-price-objective-of-gbx-340-00-argenx-se-american-depositary-shares-argx-shorts-up-by-67-6/